|
시장보고서
상품코드
2088691
내시경 시장 : 제품 유형, 기술, 사용 형태, 용도, 최종 사용자별 - 세계 시장 예측(2026-2032년)Endoscopes Market by Product Type, Technology, Usage Mode, Application, End User - Global Forecast 2026-2032 |
||||||
360iResearch
내시경 시장은 2032년까지 연평균 복합 성장률(CAGR) 6.92%로 성장해 364억 9,000만 달러 규모로 확대될 것으로 예측됩니다.
| 주요 시장 통계 | |
|---|---|
| 기준 연도(2025년) | 228억 4,000만 달러 |
| 추정 연도(2026년) | 243억 3,000만 달러 |
| 예측 연도(2032년) | 364억 9,000만 달러 |
| CAGR(%) | 6.92% |
요약 : 내시경 시장 전망
내시경 시장은 단순한 시술 지원 분야를 넘어, 최소 침습 진단, 영상 유도 치료, 그리고 가치 기반 의료의 전략적 축으로 전환되고 있습니다. 수요는 대장·위·폐·부인과·비뇨기과 질환의 부담 증가, 암 검진 경로의 확대, 고령화, 그리고 입원 기간, 시술에 따른 합병증, 회복 기간을 단축할 수 있는 저침습 치료로의 꾸준한 전환 등, 충분히 입증된 임상적 동향에 의해 뒷받침되고 있습니다.
내시경 분야의 획기적인 변화
내시경 의료의 양상은 첨단 영상 기술, 진료 현장의 변화, 그리고 더욱 엄격해진 안전성에 대한 기대가 맞물리면서 재편되고 있습니다. 고해상도, 4K, 협대역 이미징, 형광 이미징, 공초점 이미징, 기타 영상 강화 기술을 통해 점막의 가시화 및 병변의 특성 평가가 향상되고 있는 한편, 치료용 액세서리의 등장으로 내시경의 역할은 진단에 그치지 않고 조직 절제, 지혈, 비만 치료, 폐 중재술, 결석 관리, 비뇨기과 치료로 확대되고 있습니다.
내시경에 대한 인공지능의 누적 영향
인공지능(AI)은 단순한 개별 기능이 아니라, 내시경의 전체 밸류체인에 걸쳐 누적되는 힘으로 자리 잡고 있습니다. 임상 현장에서는 AI를 활용한 감지 및 특징 분석 도구가 도입되어, 대장 내시경 검사 시 용종 감지, 상부 위장관 검사 시 병변 인식, 워크플로우 기록, 채취 시간 모니터링, 장 준비 상태 평가, 자동 보고서 작성 지원 등 품질 지표 관리에 활용되고 있습니다. 주요 시장에서 발표된 동료 심사를 거친 연구와 규제 당국의 승인을 통해, 특히 누락률 감소, 실시간 의사결정 지원, 영상 분석의 표준화 측면에서 임상 의사의 판단을 보완하는 수단으로서 AI에 대한 신뢰가 높아지고 있습니다.
주요 지역별 분석 : 전 세계 내시경 수요 동향
아시아태평양은 중국, 일본, 인도, 한국, 호주 등 각국의 막대한 환자 수, 의료비 증가, 민간 병원 네트워크의 확대, 전문의 확보의 진전, 그리고 전국적인 검진 프로그램에 힘입어 가장 활기찬 내시경 시장 중 하나로 자리매김하고 있습니다. 일본은 소화기 내시경 검사 분야에서 깊은 임상 전문 지식과 체계적인 암 검진 경험을 갖춘, 기술 집약형 시장으로 자리매김하고 있습니다. 한편, 중국과 인도에서는 진단 역량이 주요 도시(1급 도시) 이외의 지역으로 확대되고, 국내 생산을 통한 접근성이 개선됨에 따라 검사 건수가 대폭 증가하고 있습니다. 한국과 호주에서는 품질 기준의 확립, 조기 진단 절차의 정비, 그리고 첨단 영상 기술에 대한 높은 수용성을 통해 내시경 검사의 보급이 지속적으로 확대되고 있습니다.
아세안(ASEAN), GCC, EU, 브릭스(BRICS), G7, 나토(NATO)의 주요 그룹 분석
인도네시아, 태국, 말레이시아, 싱가포르, 베트남, 필리핀에서 병원의 수용 능력, 전문 의료 서비스, 민간 의료 부문의 진출이 확대됨에 따라 아세안 시장은 성장세를 보이고 있습니다. 싱가포르와 태국은 복잡한 소화기 내시경, 복강경, 치료용 내시경 시술 분야에서 비교적 발전해 있는 반면, 아세안(ASEAN)의 더 큰 규모의 신흥 경제국에서는 임상 연수, 자금 조달 모델, 보험 적용 범위 확대, 주요 대도시권 이외 지역에서의 접근성 개선으로 이어지는 장기적인 기회가 예상됩니다. GCC 국가들은 첨단 의료 대응 병원, 디지털 헬스 인프라, 전문 의료 센터, 의료 관광 체계에 대한 투자를 확대하고 있으며, 이에 따라 고품질 영상 진단 플랫폼, 통합형 내시경실, 특정 시술용 일회용 솔루션, 그리고 충실한 서비스 지원에 대한 수요가 뒷받침되고 있습니다.
내시경 시장의 우선순위 설정에 관한 주요 국가의 인사이트
미국은 선별 검사 지침, 높은 검사 건수, FDA 규제 하의 의료기기 승인, 외래수술센터(ASC)의 보급, 그리고 AI 지원 영상 진단, 일회용 내시경, 첨단 치료 플랫폼에 대한 수요에 힘입어 내시경 분야의 혁신과 보급의 중심지가 되고 있습니다. 캐나다는 공공 자금을 통한 케어 패스웨이, 품질 중심의 조달, 내구성이 뛰어나고 유지보수가 용이한 시스템에 대한 안정적인 수요를 바탕으로 그 뒤를 따르고 있습니다. 한편, 멕시코에서는 민간 병원의 수용 능력, 의료 관광, 국경을 초월한 전문 의료 서비스의 확대가 진행되고 있습니다. 브라질은 라틴아메리카에서 검사 및 치료 규모, 전문의 네트워크, 병원의 현대화 측면에서 선도적인 위치를 차지하고 있지만, 공공 부문 예산의 변동이나 보상액의 격차가 구매 주기에 영향을 미칠 가능성이 있습니다.
내시경 업계의 리더를 위한 실천적인 제안
업계 리더는 단순한 하드웨어 판매보다는 통합된 내시경 생태계 구축을 우선시해야 합니다. 경쟁 우위는 내시경 본체, 영상 처리 장치, 영상 처리 소프트웨어, 부속품, 재처리 지원, 서비스 계약, 교육, 데이터 연결성을 결합하여 측정 가능한 임상적 및 운영적 성과로 이어지게 함으로써 확보할 수 있습니다. 제품 포트폴리오는 모듈식 플랫폼, 자금 조달 옵션, 지역 맞춤형 서비스 모델, 수리 프로그램 및 용도별 일회용 솔루션을 통해 고급 병원 수요와 비용 효율성을 중시하는 환경 모두에 부응해야 합니다.
내시경 시장 인텔리전스의 조사 방법
본 요약본은 널리 인정받는 헬스케어 시장 정보 분석 관행에 부합하는 체계적인 1차 및 2차 조사 프레임워크를 활용하여 작성되었습니다. 2차 조사에는 규제 데이터베이스, 공중보건 기관, 병원의 조달 동향, 임상 지침, 과학 문헌, 제품 승인, 보험 급여 정책, 질병 부담 지표, 시술 건수에 대한 참고 데이터는 물론, 내시경, 시각화 시스템, 재처리 기술 및 최소 침습 시술과 관련된 수출입 지표 분석이 포함됩니다.
결론 : 내시경 시장의 전략적 전망
세계 내시경 시장은 지능형 시각화, 최소 침습 치료, 철저한 감염 관리, 디지털 통합, 그리고 전문 진단에 대한 접근성 확대가 특징인 단계에 접어들고 있습니다. 내시경 검사는 소화기내과, 호흡기내과, 비뇨기과, 산부인과, 이비인후과, 정형외과 및 일반외과에 걸친 암 검진, 만성 질환 관리, 응급 의료, 치료적 개입에 필수적이기 때문에 수요가 꾸준히 증가하고 있습니다.
자주 묻는 질문
목차
제1장 서문
제2장 조사 방법
제3장 주요 요약
제4장 시장 개요
제5장 시장 인사이트
제6장 AI의 누적 영향(2026년)
제7장 내시경 시장 : 제품 유형별
제8장 내시경 시장 : 기술별
제9장 내시경 시장 : 사용 모드별
제10장 내시경 시장 : 용도별
제11장 내시경 시장 : 최종 사용자별
제12장 내시경 시장 : 지역별
제13장 내시경 시장 : 그룹별
제14장 내시경 시장 : 국가별
제15장 경쟁 구도
제16장 기업 개요
KTH 26.07.22The Endoscopes Market is projected to grow by USD 36.49 billion at a CAGR of 6.92% by 2032.
| KEY MARKET STATISTICS | |
|---|---|
| Base Year [2025] | USD 22.84 billion |
| Estimated Year [2026] | USD 24.33 billion |
| Forecast Year [2032] | USD 36.49 billion |
| CAGR (%) | 6.92% |
Executive Summary: Endoscopes Market Outlook
The endoscopes market is moving from a procedure-support category to a strategic pillar of minimally invasive diagnosis, image-guided therapy, and value-based care. Demand is supported by well-documented clinical trends, including the rising burden of colorectal, gastric, lung, gynecologic, and urologic conditions; expanding cancer screening pathways; aging populations; and the steady shift from open surgery to less invasive interventions that can reduce hospital length of stay, procedural morbidity, and recovery time.
Market performance is shaped by the continued expansion of flexible endoscopy, rigid endoscopy, capsule endoscopy, single-use endoscopes, video processing platforms, visualization software, endoscopic ultrasound, robotic-assisted endoscopy, and reprocessing systems. Hospitals, ambulatory surgery centers, specialty clinics, and diagnostic centers are prioritizing high-definition imaging, infection prevention, workflow efficiency, interoperability, and lifecycle cost control. As a result, manufacturers that combine optical precision, ergonomic design, digital integration, regulatory compliance, clinical evidence, and service reliability are best positioned to strengthen their role in the global endoscopes industry.
Transformative Shifts in the Endoscopy Landscape
The endoscopy landscape is being reshaped by the convergence of advanced imaging, site-of-care migration, and stricter safety expectations. High-definition, 4K, narrow-band imaging, fluorescence imaging, confocal imaging, and other image-enhancement technologies are improving mucosal visualization and lesion characterization, while therapeutic accessories are expanding the role of endoscopy beyond diagnosis into tissue resection, hemostasis, bariatric procedures, pulmonary interventions, stone management, and urologic treatment.
A second structural shift is the growing preference for ambulatory and outpatient endoscopy where reimbursement models, patient convenience, and procedure efficiency align. At the same time, infection-control requirements have increased scrutiny of reusable scopes, high-level disinfection, drying, storage, and traceability following documented concerns around device-associated contamination. This has accelerated interest in single-use endoscopes for selected applications, particularly where cross-contamination risk, availability constraints, urgent bedside access, or repair costs are material. Suppliers are also facing pressure to build resilient supply chains for image sensors, light sources, polymers, precision optics, semiconductors, and electronic components while meeting stricter environmental and regulatory expectations.
Cumulative Impact of Artificial Intelligence on Endoscopes
Artificial intelligence is becoming a cumulative force across the endoscopy value chain rather than a stand-alone feature. In clinical use, AI-assisted detection and characterization tools are being adopted to support polyp detection in colonoscopy, lesion recognition in upper gastrointestinal procedures, workflow documentation, and quality metrics such as withdrawal-time monitoring, bowel preparation assessment, and automated reporting support. Peer-reviewed studies and regulatory clearances in major markets have strengthened confidence in AI as an adjunct to clinician judgment, particularly for reducing miss rates, supporting real-time decision-making, and standardizing image interpretation.
Beyond the procedure room, AI is influencing scheduling, device utilization, predictive maintenance, inventory planning, training simulation, case prioritization, and post-procedure documentation. The commercial impact depends on integration with endoscopy towers, electronic health records, picture archiving systems, cybersecurity controls, and reimbursement evidence. Industry leaders should treat AI as a regulated clinical workflow capability that requires prospective validation, bias assessment, human oversight, explainability, data governance, and continuous performance monitoring across diverse patient populations and care settings.
Key Regional Insights: Global Endoscopes Demand Patterns
Asia-Pacific is one of the most dynamic endoscopes markets, driven by large patient populations, rising healthcare expenditure, expanding private hospital networks, broader specialist availability, and national screening programs in countries such as China, Japan, India, South Korea, and Australia. Japan remains a technology-intensive market with deep clinical expertise in gastrointestinal endoscopy and structured cancer screening experience, while China and India offer significant procedural expansion as diagnostic capacity moves beyond tier-one cities and domestic manufacturing improves access. South Korea and Australia continue to reinforce adoption through quality standards, early diagnostic pathways, and high acceptance of advanced visualization technologies.
North America benefits from established colorectal cancer screening pathways, sophisticated hospital infrastructure, strong adoption of disposable endoscopy in selected settings, and a favorable innovation ecosystem anchored by the United States and Canada. The region is also shaped by robust regulatory oversight, ambulatory surgery center penetration, infection-prevention protocols, and provider demand for systems that improve throughput and documentation quality. Latin America is advancing through private-sector investment, Brazil- and Mexico-led hospital modernization, and growing access to minimally invasive procedures, although pricing sensitivity, currency volatility, and uneven reimbursement remain constraints on broader adoption.
Europe continues to emphasize quality assurance, patient safety, sustainability, traceability, and regulatory compliance under the EU Medical Device Regulation, with Germany, France, Italy, Spain, and the United Kingdom serving as major demand centers. The Middle East is expanding advanced endoscopy through tertiary hospitals, medical tourism, and government-backed healthcare transformation programs, particularly in GCC countries where digital health and specialty care investments are increasing demand for premium visualization platforms. Africa remains an access-led opportunity where urban specialty centers are adopting endoscopy faster than rural systems, making affordability, workforce training, maintenance, service uptime, and reprocessing infrastructure essential to market development.
Key Group Insights Across ASEAN, GCC, EU, BRICS, G7, and NATO
ASEAN markets are gaining momentum as Indonesia, Thailand, Malaysia, Singapore, Vietnam, and the Philippines expand hospital capacity, specialist services, and private healthcare participation. Singapore and Thailand are comparatively advanced in complex gastrointestinal, laparoscopic, and therapeutic endoscopy procedures, while larger emerging ASEAN economies present long-term opportunities tied to clinical training, financing models, broader insurance coverage, and improved access outside major metropolitan areas. The GCC is investing in high-acuity hospitals, digital health infrastructure, specialty centers, and medical tourism capabilities, supporting demand for premium visualization platforms, integrated endoscopy suites, single-use solutions for selected procedures, and strong service support.
The European Union remains a compliance- and quality-driven endoscopes market, where MDR requirements, procurement transparency, sustainability expectations, and standardized safety protocols influence product strategy and post-market evidence requirements. BRICS countries represent a mix of scale and localization opportunities: China and India are major procedural expansion engines, Brazil and South Africa are regional anchors for specialist care, and Russia's demand is shaped by import substitution, public procurement, and geopolitical constraints. G7 countries account for substantial premium endoscopy adoption due to mature reimbursement systems, advanced clinical guidelines, high procedure volumes, and strong quality assurance practices. NATO markets overlap significantly with high-income North American and European systems, where standardization, cybersecurity, supply continuity, equipment readiness, and emergency preparedness increasingly influence procurement decisions for connected endoscopy platforms.
Key Country Insights for Endoscopes Market Prioritization
The United States is the leading innovation and adoption center for endoscopes, supported by screening guidelines, high procedure volumes, FDA-regulated device approvals, ambulatory surgery center penetration, and demand for AI-assisted imaging, single-use endoscopes, and advanced therapeutic platforms. Canada follows with publicly funded care pathways, quality-focused procurement, and steady demand for durable, serviceable systems, while Mexico is expanding private hospital capacity, medical tourism, and cross-border specialty services. Brazil leads Latin America in procedural scale, specialist networks, and hospital modernization, although public-sector budget variability and reimbursement disparities can affect purchasing cycles.
In Europe, the United Kingdom is focused on reducing diagnostic backlogs and improving cancer referral pathways, particularly through endoscopy capacity expansion and workforce initiatives. Germany remains a high-value market with advanced hospital infrastructure, engineering-led procurement, and strong adoption of premium visualization technologies, while France benefits from structured screening, public healthcare access, and quality-oriented clinical pathways. Russia is increasingly shaped by localization policies, procurement controls, and supply-chain constraints. Italy and Spain continue to invest in gastrointestinal, urologic, gynecologic, respiratory, and ENT endoscopy as aging populations and chronic disease burdens increase procedure demand.
In Asia-Pacific, China is scaling endoscopy access rapidly through hospital expansion, domestic manufacturing capabilities, clinical training, and policy support for earlier cancer detection. India's growth is tied to urban multispecialty hospitals, rising cancer awareness, expanding health insurance participation, and improving affordability across diagnostic and therapeutic procedures. Japan maintains leadership in advanced gastrointestinal endoscopy practice, early cancer detection, optical technology, and high clinical quality standards. Australia reflects strong guideline adherence, public-private service delivery, and rigorous quality standards, while South Korea is an early adopter of sophisticated imaging, minimally invasive surgical platforms, and technology-enabled screening workflows.
Actionable Recommendations for Endoscopy Industry Leaders
Industry leaders should prioritize integrated endoscopy ecosystems rather than isolated hardware sales. Competitive advantage will come from combining scopes, processors, imaging software, accessories, reprocessing support, service contracts, training, and data connectivity into measurable clinical and operational outcomes. Product portfolios should address both premium hospital demand and cost-sensitive settings through modular platforms, financing options, localized service models, repair programs, and application-specific single-use solutions.
Manufacturers should expand evidence generation around detection accuracy, procedure efficiency, infection prevention, total cost of ownership, uptime, sustainability, and clinical workflow improvement. AI-enabled features require robust clinical validation, clear labeling, cybersecurity-by-design, post-market surveillance, and transparent governance for data use. Commercial teams should align market access strategies with screening programs, ambulatory care expansion, and procurement requirements, while supply-chain leaders should diversify critical components, strengthen regional distribution, and maintain repair capacity to reduce downtime for high-volume endoscopy units.
Research Methodology for Endoscopes Market Intelligence
This executive summary is developed using a structured secondary and primary research framework aligned with recognized healthcare market intelligence practices. Secondary research includes analysis of regulatory databases, public health agencies, hospital procurement trends, clinical guidelines, scientific literature, product approvals, reimbursement policies, disease-burden indicators, procedure-volume references, and import-export indicators relevant to endoscopes, visualization systems, reprocessing technologies, and minimally invasive procedures.
Primary validation is conducted through structured inputs from manufacturers, distributors, clinicians, procurement leaders, service providers, regulatory specialists, and regional market experts. Findings are triangulated across demand-side indicators, supply-side capacity, technology adoption, pricing behavior, clinical evidence, regulatory developments, and service infrastructure. The methodology emphasizes verified public data, expert interpretation, source consistency, and practical relevance to ensure insights are evidence-based and suitable for executive decision-making without relying on unverified market sizing, market share, or forecasting claims.
Conclusion: Strategic Outlook for the Endoscopes Market
The global endoscopes market is entering a phase defined by intelligent visualization, minimally invasive therapy, infection-control discipline, digital integration, and wider access to specialty diagnostics. Demand is durable because endoscopy is embedded in cancer screening, chronic disease management, emergency care, and therapeutic intervention across gastroenterology, pulmonology, urology, gynecology, ENT, orthopedics, and general surgery.
Growth will not be uniform across regions, care settings, or clinical applications. The strongest performers will be organizations that adapt to regional procurement realities, demonstrate clinical and economic value, integrate AI responsibly, and support providers with training, service, uptime assurance, compliant reprocessing, and single-use alternatives where clinically justified. As healthcare systems seek earlier diagnosis, safer procedures, and more efficient care delivery, endoscopes will remain central to the future of precision, patient-centered medicine.
Table of Contents
1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Definition
- 1.3. Market Segmentation & Coverage
- 1.4. Years Considered for the Study
- 1.5. Currency Considered for the Study
- 1.6. Language Considered for the Study
- 1.7. Key Stakeholders
2. Research Methodology
- 2.1. Introduction
- 2.2. Research Design
- 2.2.1. Primary Research
- 2.2.2. Secondary Research
- 2.3. Research Framework
- 2.3.1. Qualitative Analysis
- 2.3.2. Quantitative Analysis
- 2.4. Market Size Estimation
- 2.4.1. Top-Down Approach
- 2.4.2. Bottom-Up Approach
- 2.5. Data Triangulation
- 2.6. Research Outcomes
- 2.7. Research Assumptions
- 2.8. Research Limitations
3. Executive Summary
- 3.1. Introduction
- 3.2. CXO Perspective
- 3.3. Market Size & Growth Trends
- 3.4. Market Share Analysis, 2025
- 3.5. FPNV Positioning Matrix, 2025
- 3.6. New Revenue Opportunities
- 3.7. Next-Generation Business Models
- 3.8. Industry Roadmap
4. Market Overview
- 4.1. Introduction
- 4.2. Industry Ecosystem & Value Chain Analysis
- 4.2.1. Supply-Side Analysis
- 4.2.2. Demand-Side Analysis
- 4.2.3. Stakeholder Analysis
- 4.3. Market Dynamics
- 4.3.1. Key Drivers
- 4.3.2. Key Restraints
- 4.3.3. Key Opportunities
- 4.3.4. Key Challenges
- 4.4. Porter's Five Forces Analysis
- 4.5. PESTLE Analysis
- 4.6. Market Outlook
- 4.6.1. Near-Term Market Outlook (0-2 Years)
- 4.6.2. Medium-Term Market Outlook (3-5 Years)
- 4.6.3. Long-Term Market Outlook (5-10 Years)
- 4.7. Go-to-Market Strategy
5. Market Insights
- 5.1. Consumer Insights & End-User Perspective
- 5.2. Consumer Experience Benchmarking
- 5.3. Opportunity Mapping
- 5.4. Distribution Channel Analysis
- 5.5. Pricing Trend Analysis
- 5.6. Regulatory Compliance & Standards Framework
- 5.7. ESG & Sustainability Analysis
- 5.8. Disruption & Risk Scenarios
- 5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Endoscopes Market, by Product Type
- 7.1. Capsule Endoscopes
- 7.1.1. Esophageal Capsule Endoscopes
- 7.1.2. Large Capsule Endoscopes
- 7.1.3. Small Capsule Endoscopes
- 7.2. Flexible Endoscopes
- 7.2.1. Arthroscopes
- 7.2.1.1. Knee Arthroscopes
- 7.2.1.2. Shoulder Arthroscopes
- 7.2.2. Bronchoscopes
- 7.2.2.1. Diagnostic Bronchoscopes
- 7.2.2.2. Therapeutic Bronchoscopes
- 7.2.3. Gi Endoscopes
- 7.2.3.1. Colonoscopes
- 7.2.3.2. Enteroscopes
- 7.2.3.3. Gastroscopes
- 7.2.4. Urological Endoscopes
- 7.2.4.1. Cystoscopes
- 7.2.4.2. Nephroscopes
- 7.2.4.3. Ureteroscopes
- 7.2.1. Arthroscopes
- 7.3. Rigid Endoscopes
- 7.3.1. Hysteroscopes
- 7.3.2. Laparoscopes
- 7.3.3. Otoscopes
- 7.3.4. Proctoscopes
- 7.4. Single-Use Endoscopes
8. Endoscopes Market, by Technology
- 8.1. Digital Endoscopes
- 8.1.1. 4K Digital
- 8.1.2. Hd Digital
- 8.2. Fiber Optic Endoscopes
- 8.3. Video Endoscopes
- 8.3.1. 4K Video
- 8.3.2. High Definition Video
- 8.3.3. Standard Definition Video
- 8.4. Wireless Capsule Endoscopes
9. Endoscopes Market, by Usage Mode
- 9.1. Reusable
- 9.2. Single-Use
10. Endoscopes Market, by Application
- 10.1. Arthroscopy
- 10.2. Gastrointestinal
- 10.3. Gynecological
- 10.4. Laparoscopy
- 10.5. Pulmonary
- 10.6. Urological
- 10.6.1. Cystoscopy
- 10.6.2. Ureteroscopy
11. Endoscopes Market, by End User
- 11.1. Ambulatory Surgical Centers
- 11.1.1. Gastrointestinal Ascs
- 11.1.2. Orthopedic Ascs
- 11.2. Diagnostic Centers
- 11.3. Hospitals
- 11.3.1. Community Hospitals
- 11.3.2. Tertiary Hospitals
- 11.4. Specialty Clinics
12. Endoscopes Market, by Region
- 12.1. Asia-Pacific
- 12.2. North America
- 12.3. Latin America
- 12.4. Europe
- 12.5. Middle East
- 12.6. Africa
13. Endoscopes Market, by Group
- 13.1. ASEAN
- 13.2. GCC
- 13.3. European Union
- 13.4. BRICS
- 13.5. G7
- 13.6. NATO
14. Endoscopes Market, by Country
- 14.1. United States
- 14.2. Canada
- 14.3. Mexico
- 14.4. Brazil
- 14.5. United Kingdom
- 14.6. Germany
- 14.7. France
- 14.8. Russia
- 14.9. Italy
- 14.10. Spain
- 14.11. China
- 14.12. India
- 14.13. Japan
- 14.14. Australia
- 14.15. South Korea
15. Competitive Landscape
- 15.1. Market Concentration Analysis, 2025
- 15.1.1. Concentration Ratio (CR)
- 15.1.2. Herfindahl Hirschman Index (HHI)
- 15.2. Recent Developments & Impact Analysis, 2025
- 15.3. Product Portfolio Analysis, 2025
- 15.4. Benchmarking Analysis, 2025
16. Company Profiles
- 16.1. 3NT Medical, Inc.
- 16.2. Altek Corporation
- 16.3. Ambu A/S
- 16.4. B. Braun Melsungen AG
- 16.5. BioVision Technologies, LLC by ATL Technology, LLC
- 16.6. Boston Scientific Corporation
- 16.7. Daichuan Medical (Shenzhen) Co., Ltd
- 16.8. Dyne Medical Group
- 16.9. EnlightenVue, Inc.
- 16.10. Flexicare Medical Limited
- 16.11. Fujifilm Holdings Corporation
- 16.12. Hill-Rom Holdings, Inc.
- 16.13. Hoya Corporation
- 16.14. Integrated Endoscopy
- 16.15. Intersurgical Ltd.
- 16.16. IQ Endoscopes Limited
- 16.17. J-Sol Medical Co., Ltd.
- 16.18. Karl Storz SE & Co. KG
- 16.19. NeoScope, Inc.
- 16.20. Olympus Corporation
- 16.21. OTU Medical Inc.
- 16.22. Parburch Medical Developments Ltd
- 16.23. Roper Technologies, Inc.
- 16.24. Scivita Medical Technology Co., Ltd.
- 16.25. STERIS Corporation
- 16.26. Teleflex Incorporated
- 16.27. The Cooper Companies, Inc.
- 16.28. The Surgical Company
- 16.29. Zhejiang Geyi Medical Instrument Co., Ltd.
- 16.30. Zsquare Ltd.
